ArticlePDF Available

The Antidepressant-Like Effects of Punica granatum (Pomegranate) Extract in Mice

Authors:
Chinese Medicine, 2014, 5, 1-6
Published Online March 2014 in SciRes. http://www.scirp.org/journal/cm
http://dx.doi.org/10.4236/cm.2014.51001
How to cite this paper: Jahromy, M.H., Khakpour, S. and Khorgami, Z. (2014) The Antidepressant-Like Effects of Punica
granatum (Pomegranate) Extract in Mice. Chinese Medicine, 5, 1-6.
http://dx.doi.org/10.4236/cm.2014.51001
The Antidepressant-Like Effects of Punica
granatum (Pomegranate) Extract in Mice
Mahsa Hadipour Jahromy1*, Shahrzad Khakpour2, Zhinoos Khorgami3
1Department of Pharmacology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
2Department of Physiology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
3Iranian Tissue Bank and Research Center, Tehran University of Medical Sciences, Tehran, Iran
Email: *Jahromymh@yahoo.com
Received 9 December 2013; revised 18 January 2014; accepted 3 February 2014
Copyright © 2014 by authors and Scientific Research Publishing Inc.
This work is licensed under the Creative Commons Attribution International License (CC BY).
http://creativecommons.org/licenses/by/4.0/
Abstract
The aim of the present work is to evaluate the putative antidepressant-like effects of pomegranate
fruit extract including seeds (PFE) on the performance of male mice in the forced swimming test
(FST), after acute administration, after short-term treatment (7 days) and, after repeated admin-
istration in a 24-h period (24, 12 and 1 h before swimming test). A single dose (20 ml/kg p.o.) of
PFE, in male mice provoked a significant reduction of the immobility time. Such effect was also
observed with short-term treatment (7 days) with doses of 1 and 10 ml/kg/day of PFE. Moreover,
it was noted that there were important differences in the onset of the antidepressant-like effect in
the FST, depending on the modality of treatment with PFE. Both efficacy and potency were higher
when repeated administration of PFE was used, and surprisingly the dose of 10 ml/kg (24, 12 and
1 h before swimming test) was as effective as Fluoxetine. In the same way, the short term admin-
istration (7 days) improved significantly efficacy and potency of the PFE in comparison to a single
dose treatment. These results indicate an antidepressant-like profile of action for PFE which de-
serves further research.
Keywords
Pomegranate; Antidepressant Effect; Forced Swimming Test
1. Introduction
Depression is a major disease affecting nearly 13% - 20% of the population [1]. Roughly, 90% of patients with
depressive symptoms suffer from mild to moderate depression, while only 10% are severely depressed. In mild
*
Corresponding author.
M. H. Jahromy et al.
2
to moderate depression, in particular, some practitioners and patients are reluctant to use standard antidepres-
sants like tricyclic antidepressants or specific serotonin reuptake inhibitors (SSRIs), because of their side effects.
Therefore, additional treatment strategies with fewer side effect profile, credible benefits and moderate costs are
of particular interest [2] [3]. In the search for new molecules useful for the treatment of neurological disorders,
medicinal plant research, worldwide, has progressed constantly, demonstrating the pharmacological effective-
ness of different plant species in a variety of animal models [4]. At the present time, forced swimming test (FST)
is the most widely used model for assessing potential antidepressant activity in rodents, following acute and
short-term treatment [5].
Pomegranate (Punica granatum), a small tree originating in the Orient, belongs to the Punicaceae family [6].
It is grown mainly in Iran, India and in most Near and Far East countries. The main use of pomegranate is as ta-
ble fruit, but large amounts are used in the beverage and liquor industries [7]. In folk medicine, pomegranate
preparations have a number of therapeutic actions [8].
The edible part of pomegranate is rich in anthocyanins thus; the major class of phytochemical present in po-
megranate is the polyphenols and includes flavonoids, condensed tannins and hydrolysable tannins. Hydrolysa-
ble tannins are predominant polyphenols found in pomegranate juice and account for 92% of its antioxidant ac-
tivity [9] [10].
The present research was undertaken to study the duration of immobility in mice in the FST, after acute ad-
ministration, after short-term treatment (7 days) and, after repeated administration in a 24-h period (24, 12 and 1 h
before swimming test) following oral ingestion of a standardized preparation of pomegranate fruit extract (PFE).
2. Materials and Methods
2.1. Pomegranate Extract
Pomegranates (Punica granatum L.), was collected by one of the colleagues from the agriculture garden (under
supervision of Agricultural Research Organization in Fars Province) in Shiraz, a city where known to have one
of the best pomegranate native in Iran. Then washed, chilled to 4˚C, and stored. The seeds of the fruit containing
the intact juice sacs were manually separated from the pericarp, and the whole juice extracted by the aid of elec-
tric juicer so that seeds break. Then filtered and stored in clean jars in fridge.
2.2. Animals
Male BALB/c mice, weighing 25 - 30 g were used in these experiments. They were group housed under the fol-
lowing laboratory conditions: temperature 23˚C ± 1˚C, humidity 40% - 60%, 12 h:12 h L/D cycle, lights on at
07:00 h. Food and water were available ad libitum. All the experiments were carried out between 10:00 and
15:00 h in testing rooms adjacent to the animal rooms. Each experimental group consisted of ten mice. Mice
were treated in accordance with the current law and the NIH Guide for the Care and Use of Laboratory.
2.3. Drugs
Fluoxetine (Sigma) were suspended in normal saline (0.9% NaCl).
2.4. Behavioral Tests
This test was performed according to the procedure described by Porsolt et al. [11]-[13], with slight modifica-
tions [14]. Briefly, 1 h after dosing, the animals were individually forced to swim in a transparent glass vessel
(25 cm high, 15 cm in diameter) filled with (12.5 cm high) water at 21˚C - 24˚C. The total duration of immobil-
ity (in seconds) was measured during the last 4 min of a single 6 min test session. Five groups of 10 mice were
treated acutely with single dose of vehicle, PFE (1, 10 and 20 ml/kg) p.o. (Gavage), Fluoxetine i.p. (10 mg/kg)
and 1 h later mice were individually forced to swim in the glass vessel. Other five groups of mice were short-
term treated (7 days) with a single daily dose of vehicle, PFE (1, 10 and 20 ml/kg) p.o., or Fluoxetine i.p. (10
mg/kg), and 1 h after the last administration they were individually forced to swim in same conditions. In a dif-
ferent set of experiments, five groups of 10 animals were subjected to repeated administration of three doses of
vehicle, PFE using 1, 10 and 20 ml/kg p.o., Fluoxetine i.p. (10 mg/kg), 24, 12 and 1 h prior to the swimming test.
Behaviour was monitored from the frontal side by a video camera for subsequent analysis. Mice were consid-
M. H. Jahromy et al.
3
ered immobile when they made no further attempts to escape except the movements necessary to keep their
heads above the water.
2.5. Statistical Analysis
The results are expressed as mean ± S.D, and statistical analysis of the data was performed by Origin VI. ***p <
0.001; **p < 0.01 were considered significantly different from vehicle, after non-parametric ANOVA.
3. Results
Effects of PFE on the Immobility Time
A significant shortening of the immobility time was observed when an acute dose of either 20 ml/kg p.o., of PFE
(p < 0.01) or fluoxetine (10 mg/kg i.p.) (p < 0.001) was administered to mice compared to vehicle treated ani-
mals. The reduction of immobility time, between these two mentioned groups was at the same level, statistically
(Figure 1). Short-term treatment (7 days) induced a decrease of the immobility time when the animals were ex-
posed to the FST after dosing orally, once a day, with 1 (p < 0.001) and 10 (p < 0.001) ml/kg of PFE (Figure 1).
In addition, repeated administration in a 24 h period showed a significant reduction of the immobility time with
1 (p < 0.01) and 10 ml/kg (p < 0.001) of PFE in different groups of mice submitted to FST in comparison to
control group (Figure 2).
4. Discussion
The present study characterized the effects of the administration of PFE on mice performance in FST following
acute, short-term and repeated treatment. In many previous papers the antioxidant and anti-inflammatory prop-
erties of pomegranate fruit juice in animal labs has been emphasized [15]-[18]. Also, it has been reported that
Pomegranate extract improves a depressive state and bone properties in menopausal syndrome model ovariec-
tomized mice [19]. Besides that, it was demonstrated that PFE exhibits low toxicity, no lethality, was well toler-
ated, did not induce significant changes in several behavioural and physiological parameters and is devoid of any
hypnosedative activity, when administered to mice [15]. Recently, the antidepressant action of some herbal medi-
cines has been reported focusing on polyphenols as their major component [3] [4] [14]. The edible part of pome-
granate is rich in anthocyanins thus; the major class of phytochemical present in pomegranate is the polyphenols.
Figure 1. Effect of the vehicle, fluoxetine (10 mg/kg, i.p.) and increasing single
doses of PFE (1, 10 and 20 ml/kg p.o) on the forced swimming test (FTS) in mice.
Each bar represents the mean ± SD of 10 animals. ***p < 0.001; **p < 0.01, signifi-
cantly different from vehicle, after non-parametric ANOVA.
01234
0
50
100
150
200
*
*
*
*****
*
*
**
*
*
Immobility Time (sec)
Vehicle, Flouxetine, PFE 1 ml/kg, 10 ml/kg, 20 ml/kg
One Day Treatment
Seven Days Treatment
M. H. Jahromy et al.
4
Figure 2. Effect of repeated administration of three doses in 24 h of vehicle, fluoxetine
(10 mg/kg i.p) and increasing doses of PFE (1, 10, and 20 ml/kg p.o) on the forced
swimming test (FTS) in mice. Each bar represents the mean ± SD of 10 animals. ***p <
0.001; **p < 0.01, significantly different from vehicle, after non-parametric ANOVA.
Because the pharmacotherapy of depression typically requires chronic drug treatment to obtain a full response
in terms of antidepressant effect, it is critical to perform, not only acute, but also short-term, chronic and re-
peated treatments in the FST mice model. Certainly, the administration of PFE produced a diminution of immo-
bility time of mice exposed to the FST under acute, short-term or repeated modalities. Indeed, single dose of 20
ml/kg p.o., of PFE provoked a highly significant reduction of immobility time (p < 0.01). Similar results were
also observed with short-term treatment (7 days) with single dose of 1 (p < 0.001), and 10 (p < 0.001) ml/kg/day
of PFE, but not with higher dose. Additionally, in a different set of experiments, repeated administration in a
24-h period (24, 12 and 1 h before swimming) doses of 1 (p < 0.01) and 10 (p < 0.001) ml/kg p.o., of PFE pro-
voke significant reduction of the immobility time of male mice subjected to the FST, when compared to control
group (vehicle) but not with higher dose. It is important to note that although single acute high dose, showed an-
tidepressant effect as fluoxetine, no significant effects observed in high dose of 20 mg/kg of PFE in repeated
administration. This can be interpreted as acute tolerance or tacyfilaxy that might have happened in receptor re-
sponses. Moreover, depending on the modality of treatment with PFE (acute, short-term or repeated) in the FST,
it was observed important differences in the onset of the antidepressant-like effect. In fact, both efficacy and po-
tency of PFE as antidepressant were higher when repeated administration was used, and interestingly 10 mg/kg
(24, 12 and 1 h before swimming) was as effective as fluoxetine (10 mg kg i.p.) used as positive control. In the
same way, the short term administration (7 days), improves significantly the efficacy and potency of the PFE, in
comparison to single dose treatments. These behavioural effects were similar to those seen in mice treated with
conventional antidepressant drugs, such as tricyclic, monoamine oxidase inhibitors and selective serotonine re-
uptake inhibitors agents [5] [11] [20].
5. Conclusion
In conclusion, the results of this preclinical study provide evidence about the antidepressant effects of the po-
megranate fruit extract administered either acute or repeatedly in mice. These results contribute to the scientific
validation of the indications of this plant in Iranian folk medicine. However, further experiments are needed to
identify its active compounds and the corresponding mechanisms of action. Our results encourage us to pursue
the identification of the molecules associated to the effect observed in PFE.
Acknowledgements
The authors would like to thank M. Aghakhani, for his help during experiments. The experimental work has
0
50
100
150
*
***
**
**
Immobility Time (sec)
Vehicle Fluoxetine PFE 1 ml/kg PFE 10 ml/kg PFE 20 ml/kg
M. H. Jahromy et al.
5
been done at physiology and pharmacology laboratory of medical sciences research center, Tehran Medical
Sciences Branch, Islamic Azad University.
References
[1] Licinio, J. and Wong, M.L. (1999) The Role of Inflammatory Mediators in the Biology of Major Depression: Central
Nervous System Cytokines Modulate the Biological Substrate of Depressive Symptoms, Regulate Stress-Responsive
Systems, and Contribute to Neurotoxicity and Neuroprotection. Molecular Psychiatry, 4, 317-327.
[2] Ernst, E. (1995) St. John’s Wort, an Antidepressant? A Systematic, Criteria-Based Review. Phytomedicine, 2, 67-71.
http://dx.doi.org/10.1016/S0944-7113(11)80051-6
[3] Laakmann, G., Dienel, A. and Kieser, M. (1998) Clinical Significance of Hyperforin for the Efficacy of Hypericum
Extracts on Depressive Disorders of Different Severities. Phytomedicine, 5, 435-442.
http://dx.doi.org/10.1016/S0944-7113(98)80039-1
[4] Zhang, Z.J. (2004) Therapeutic Effects of Herbal Extracts and Constituents in Animal Models of Psychiatric Disorders.
Life Sciences, 75, 1659-1699. http://dx.doi.org/10.1016/j.lfs.2004.04.014
[5] Cryan, J.F., Page, M.E. and Lucki, I. (2005) Differential Behavioural Effects of the Antidepressant Reboxetine, Fluo-
xetine, and Moclobemide in a Modified Forced Swim Test Following Chronic Treatment. Psychopharmacology, 182,
335-344. http://dx.doi.org/10.1007/s00213-005-0093-5
[6] Harde, H., Schumacher, W., Firbas, F. and Denffer, D. (1970) Strasburg’s Textbook of Botany.
[7] Nagy, P., Shaw, P.E. and Wardowski, W.F. (1990) Fruits of Tropical and Subtropical Origin.
[8] Bianchini, F. and Corbetta, F. (1979) Health Plants of the World.
[9] Longtin, R. (2003) The Pomegranate: Nature’s Power Fruit? Journal of the National Cancer Institute, 95, 346-348.
http://dx.doi.org/10.1093/jnci/95.5.346
[10] Gil, M.I., Tomas-Barberan, F.A., Hess-Pierce, B., Holcraft, D.M. and Kedar, A.A. (2000) Antioxidant Activity of Po-
megranate Juice and Its Relationship with Phenolic Composition and Processing. Journal of Agricultural and Food
Chemistry, 10, 4581-4589. http://dx.doi.org/10.1021/jf000404a
[11] Porsolt, R.D., Le Pichon, M. and Jalfre, M. (1977) Depression: A New Animal Model Sensitive to Antidepressant
Treatments. Nature, 266, 730-732. http://dx.doi.org/10.1038/266730a0
[12] Porsolt, R.D., Brossard, G., Hautbois, C. and Roux, S. (2001) Rodent Models of Depression: Forced Swimming and
Tail Suspension Behavioural Despair Tests in Rats and Mice. In: Crawley, J.N., Ed., Current Protocols in Neuros-
cience, John Wiley & Sons, Inc., Hoboken, pp. 8.10A.1-8.10A.10.
[13] Petit-Demouliere, B., Chenu, F. and Bourin, M. (2005) Forced Swimming Test in Mice: A Review of Antidepressant
Activity. Psychopharmacology, 177, 245-255. http://dx.doi.org/10.1007/s00213-004-2048-7
[14] Hellión-Ibarrola, M.C., Ibarrola, D.A., Montalbetti, Y., Kennedy, M.L., Heinichen, O., Campuzano, M., Ferro, E.A.,
Alvarenga, N., Tortoriello, J., De Lima, T.C. and Mora, S. (2008) The Antidepressant-Like Effects of Aloysia polys-
tachya (Griseb.) Moldenke (Verbenaceae) in Mice. Phytomedicine, 15, 478-483.
[15] Lansky, E.P. and Newmana, R.A. (2007) Punica granatum (Pomegranate) and Its Potential for Prevention and Treat-
ment of Inflammation and Cancer. Journal of Ethnopharmacology, 109, 177-206.
http://dx.doi.org/10.1016/j.jep.2006.09.006
[16] Schubert, S.Y., Lansky, E.Ph. and Neeman, I. (1999) Antioxidant and Eicosanoid Enzyme Inhibition Properties of Po-
megranate Seed Oil and Fermented Juice Flavonoids. Journal of Ethnopharmacology, 66, 11-17.
http://dx.doi.org/10.1016/S0378-8741(98)00222-0
[17] N.P. Seeram, L.S. Adams, S.M. Henning, Y.T. Niu, Y.J. Zhang, M.G. Nair and D. Heber (2005) In Vitro Antiprolifera-
tive, Apoptotic and Antioxidant Activities of Punicalagin, Ellagic acid and a Total Pomegranate Tannin Extract Are
Enhanced in Combination with Other Polyphenols as Found in Pomegranate Juice. The Journal of Nutritional Bioche-
mistry, 16, 360-367. http://dx.doi.org/10.1016/j.jnutbio.2005.01.006
[18] Aslama, M.N., Lansky, E.Ph. and Varani, J. (2006) Pomegranate as a Cosmeceutical Source: Pomegranate Fractions
Promote Proliferation and Procollagen Synthesis and Inhibit Matrix Metalloproteinase-1 Production in Human Skin
Cells. Journal of Ethnopharmacology, 103, 311-318. http://dx.doi.org/10.1016/j.jep.2005.07.027
[19] Mori-Okamoto, J., Otawara-Hamamoto, Y., Yamato, H. and Yoshimur, H. (2004) Pomegranate Extract Improves a
Depressive State and Bone Properties in Menopausal Syndrome Model Ovariectomized Mice. Journal of Ethnophar-
macology, 92, 93-101. http://dx.doi.org/10.1016/j.jep.2004.02.006
[20] Borsini, F. and Meli, A. (1988) Is the Forced Swimming Test a Suitable Model for Revealing Antidepressant Activity?
Psychopharmacology (Berlin), 94, 147-160.
M. H. Jahromy et al.
6
Note List of Abbreviations
Pomegranate fruit extract (PFE)
Forced swimming test (FST)
Specific serotonin reuptake inhibitors (SSRIs)
... Naveen et al. (2013) and Riaz and Khan, (2017) also showed antidepressant like activity of pomegranate juice and peel in rodents. Jahromy et al. (2014) used pomegranate fruit extract in male mice followed by monitoring performance in forced swim test and they have reported antidepressant like activity following acute, short-term and repeated administration. Pomegranate is known to contain estrogenic compounds such as estrone and estradiol which have potential antidepressant activity (van Elswijk et al. 2004). ...
... The majority of the clinical trials were non-conclusive and unable to provide strong evidence to establish the effectiveness of each natural product. [93][94][95][96][97] There is a huge gap in bringing these active herbs to patients in the clinics. There is an abundance of potential natural products that have not been examined yet. ...
Article
Full-text available
There is a gap between traditional knowledge, experimental proof and translational research into clinical studies for acceptance of traditional medicine. They are restricted by the quality of trials, flaws in study design and other important criteria that may affect their success as a clinically accepted drug. This article provides a summary of potential medicinal plants that can be used as natural psychotropic agents based on their fundamental scientific findings. Several reviews have been published that focus on a particular plant or particular neuronal disorder. This article focuses on providing a comprehensive review of different kinds of neuronal diseases, the shortcomings of psychotropic western medicine, the status of medicinal plants and their mechanism of action in various neuronal diseases. The article aims to emphasize establishing collaborative and concerted efforts between the ethnopharmacologists and western medicine practitioners to further provide scientific validation of traditional medicines.
... Naveen et al. (2013) and Riaz and Khan, (2017) also showed antidepressant like activity of pomegranate juice and peel in rodents. Jahromy et al. (2014) used pomegranate fruit extract in male mice followed by monitoring performance in forced swim test and they have reported antidepressant like activity following acute, short-term and repeated administration. Pomegranate is known to contain estrogenic compounds such as estrone and estradiol which have potential antidepressant activity (van Elswijk et al. 2004). ...
Chapter
Pomegranate (Punica granatum L.) in Mexico is a marginal fruit and ormanmental tree. Despite its wide adaptation, pomegranate is consumed sporadically and seasonally, usually as fresh fruit as decoration in Mexican food. In Mexico, pomegranate is also used in traditional herbolaria taking advantage of all parts of the fruit and the shrub...
... Naveen et al. (2013) and Riaz and Khan, (2017) also showed antidepressant like activity of pomegranate juice and peel in rodents. Jahromy et al. (2014) used pomegranate fruit extract in male mice followed by monitoring performance in forced swim test and they have reported antidepressant like activity following acute, short-term and repeated administration. Pomegranate is known to contain estrogenic compounds such as estrone and estradiol which have potential antidepressant activity (van Elswijk et al. 2004). ...
Chapter
Full-text available
Chapter 9-Pomegranate has over 2000 years of cultivation history and has been described in divine scriptures, including the Holy Quran and the Old Testament. Pomegranate trees requires, an average annual water requirement of 20 m3, a dry climate, and a 5 – 8 years duration for the fruit development and ripening. Pomegranate fruits weight ranges 375 - 500 g and its edible juice arils makes up to 26.9 – 65.6% of the fruit weight. Pomegranate is the most difficult fruit to process for its juice due to the difficulty to separate the arils from the peels. Untreated pomegranate juices (PJ) contains an excessive turbidity and it must be clarified by addition of fining agents such as albumin, bentonite, gelatin kiesel gel, polyvenylpyrrolidone or ultrafiltration. In industrial processing, the juice is concentrated to reduce volume, proper storage to resist microbial and chemical deterioration, and packaging for year-round utilization. The industrial concentration is performed by removal and subsequent concentration of aroma compounds by distillation, which is then added back to the de-aromatized juice concentrate during reconstitution step to restore the original aroma profile. Processes such as different types of pasteurization, osmotic distillation, high hydrostatic pressure, microwave, and heating are applied either separate or in combination for the processing of pomegranate juice. Regardless of the processing technique, the PJ should pass specific criteria of quality control and storage stability, such as the microbiological safety, color, total soluble solids, anthocyanins content, total phenols contents, and antioxidant activities. Greater attentions have been directed to the bioactive properties of phytochemical compounds present in pomegranate. The active compounds in pomegranate possess anti-atherosclerotic, anti-atherogenic, anti-carcinogenic, anti-diabetic, anti-diarrheal and many others biological properties. It is anticipated that the use of PJ as non-pharmacological agent in the treatment of both infectious and non-communicable diseases will find wider application in the Millennium.
... It is one of the most widely test to explore antidepressant activity (Jahromy et al. 2014). Therefore, this test was selected to explore antidepressant activity of young coconut water. ...
Article
Full-text available
In the current era, plants are frequently tested for its antidepressant potential. Therefore young coconut water, a commonly used plant based beverage, was selected to explore its antidepressant potential. Rodents were selected for this study and forced swim test was conducted to explore antidepressant activity. Analysis of brain biogenic amines using high performance liquid chromatography coupled with electrochemical detection and potentiation of noradrenaline toxicity model were also incorporated in this study to demonstrate probable antidepressant mechanism of action. Coconut water was administered orally at the dose of 4 ml/100 g. Young coconut water showed highly significant increase in struggling time (p < 0.001) in forced swim test. This suggests antidepressant effect of young coconut water. In noradrenaline toxicity model, it was observed that young coconut water is not a good adrenergic component as its lethality percentage in this test was observed 0 % unlike imipramine which showed lethality of 100 %. High performance liquid chromatography-electrochemical detection of rodent’s brain revealed decline in 5-hydroxytryptamine, noradrenaline and dopamine, with concomitant decline in metabolites 5-hydroxyindoleacetic acid, 3,4-dihydroxyphenylacetic acid, homovanillic acid and increase in 5-hydroxyindoleacetic acid/5-hydroxytryptamine ratio. Findings from the exploration of monoamines suggest antidepressant effect of young coconut water via homeostasis of monoamines synthesis.
Article
Full-text available
Depression, a debilitating mental health disorder affecting millions worldwide, con-tinues to challenge the medical community. While several pharmacological interventions ex-ist, their efficacy and side effects often warrant the exploration of alternative treatments. Natu-ral products derived from plants have gained attention for their potential antidepressant prop-erties in preclinical studies. This comprehensive review examines the antidepressant activity of various plant-based extracts through preclinical investigations and explores the underlying mechanisms of action. Our review systematically analyzes the literature, encompassing a wide range of plants. We present evidence from pre-clinical and clinical studies, highlighting the behavioural and neurochemical changes induced by these plant-derived compounds. Further-more, we delve into the potential mechanisms of action, encompassing modulation of neuro-transmitters, anti-inflammatory effects, neurogenesis promotion, and antioxidant properties. The reviewed studies suggest that numerous plants possess promising antidepressant proper-ties, potentially offering novel therapeutic avenues. However, the variability in methodologies and the need for further clinical validation underscore the complexity of translating preclinical findings into effective treatments. This review serves as a valuable resource for researchers and clinicians alike, shedding light on the current state of knowledge regarding plants with an-tidepressant potential and their underlying mechanisms of action, paving the way for future investigations and therapeutic developments in the field of depression management.
Article
Full-text available
PubMed ,Google Scholar ‫ﻳﺎﻓﺘﻪ‬ ‫ﻫﺎﻱ‬ ‫ﺍﺳﺖ‬ ‫ﭘﺮﺩﺍﺧﺘﻪ‬ ‫ﮔﺮﺍﻧﺒﻬﺎ‬ ‫ﻣﻴﻮﻩ‬ ‫ﺍﻳﻦ‬ ‫ﺧﻮﺍﺹ‬ ‫ﻣﻮﺭﺩ‬ ‫ﺩﺭ‬ ‫ﻭﺑﺮﺭﺳﻲ‬ ‫ﺑﺤﺚ‬ ‫ﻭﺑﻪ‬ ‫ﺷﺪﻩ‬ ‫ﺍﺳﺘﺨﺮﺍﺝ‬ ‫ﺟﺪﻳﺪ‬ ‫ﻋﻠﻤﻲ‬. ‫ﻫﺎ‬ ‫ﻳﺎﻓﺘﻪ‬ : ‫ﺑﺎﺭﺯ‬ ‫ﺧﺎﺻﻴﺖ‬ ‫ﻳﻚ‬ ‫ﺩﺍﺭﺍﻱ‬ ‫ﻭﺭﻳﺸﻪ‬ ‫ﻭﺑﺮگ‬ ‫ﺳﺎﻗﻪ‬ ‫ﻭ‬ ‫ﻭﻣﻴﻮﻩ‬ ‫ﮔﻞ‬ ‫ﺍﺯ‬ ‫ﺁﻥ‬ ‫ﻣﺨﺘﻠﻒ‬ ‫ﺍﺟﺰﺍء‬ ‫ﻛﻪ‬ ‫ﺍﺳﺖ‬ ‫ﮔﻴﺎﻫﻲ‬ ‫ﺍﻳﺮﺍﻧﻲ‬ ‫ﻃﺐ‬ ‫ﺩﺭ‬ ‫ﺍﻧﺎﺭ‬ ‫ﻣﻲ‬ ‫ﺍﻧـﻮﺍﻉ‬ ‫ﺗﻤﺎﻡ‬ ‫ﺩﺭ‬ ‫ﻛﻪ‬ ‫ﺧﺎﺻﻴﺖ‬ ‫ﺍﻳﻦ‬ ‫ﺑﺎﺷﻨﺪ‬ ‫ﻭﺷﻴﺮﻳﻦ‬ ‫ﺗﺮﺵ‬ ‫ﺍﺯ‬ ‫ﺍﻧﺎﺭ‬ ‫ﺗﻘﻮﻳﺖ‬ ‫ﻋﺚ‬ ‫ﺑﺎ‬ ‫ﺑﺎﺷﺪ‬ ‫ﺩﺍﺷﺘﻪ‬ ‫ﻗﺒﺾ‬ ‫ﻛﻪ‬ ‫ﺍﻱ‬ ‫ﻣﺎﺩﻩ‬ ‫ﻫﺮ‬ ‫ﺍﻳﺮﺍﻧﻲ‬ ‫ﻃﺐ‬ ‫ﺑﺮﺍﺳﺎﺱ‬ ‫ﺍﺳﺖ‬ ‫ﻗﺒﺾ‬ ‫ﺧﺎﺻﻴﺖ‬ ‫ﺩﺍﺭﺩ‬ ‫ﻭﺟﻮﺩ‬ ‫ﻭﻣﻠﺲ‬ ‫ﻣﻲ‬ ‫ﻭﺍﺭﺩ‬ ‫ﻛـﻪ‬ ‫ﻋﻀـﻮ‬ ‫ﻫﺮ‬ ‫ﺩﺭ‬ ‫ﺷﻮﺩﻭ‬ ‫ﺁﻥ‬ ‫ﺑﻪ‬ ‫ﺳﻤﻮﻡ‬ ‫ﻭﺭﻭﺩ‬ ‫ﻣﺎﻧﻊ‬ ‫ﻋﻀﻮ‬ ‫ﻋﻤﻠﻜﺮﺩﺁﻥ‬ ‫ﺗﻘﻮﻳﺖ‬ ‫ﺑﺮ‬ ‫ﺷﻮﺩﻋﻼﻭﻩ‬ ‫ﻣﻲ‬ ‫ﺷﻮﺩ‬. ‫ﺯﺧﻢ،ﻣﻤ‬ ‫ﺑﻬﺒـﻮﺩ‬ ‫ﺧـﻮﻧﺮﻳﺰﻱ،‬ ‫ﺍﺯ‬ ‫،ﻛﺒـﺪ،ﻣﻤﺎﻧﻌﺖ‬ ‫ﻣﻌـﺪﻩ‬ ‫ﺗﻘﻮﻳـﺖ‬ ‫ﺩﺭ‬ ‫ﺍﻧﺎﺭ‬ ‫ﺍﻳﻦ‬ ‫ﺑﻨﺎﺑﺮ‬ ‫ﺍﻳﺠـﺎﺩ‬ ‫ﺍﺯ‬ ‫ﺎﻧﻌـﺖ‬ ‫ﺳﺮﺩ‬ ‫ﺑﺎ‬ ‫ﻣﺸﺎﺭﻙ‬ ‫ﺭﺩﻫﺎﻱ‬ ، ‫ﺁﻟﺮ‬ ‫ﺿﺪ‬ ‫ﺣﻠﻖ،ﺍﺛﺮﺍﺕ‬ ‫ﭘﺸﺖ‬ ‫ﺗﺮﺷﺤﺎﺕ‬ ‫ﻛﺮﺩﻥ‬ ‫ﻭﺑﻴﻨﻲ،ﺑﺮﻃﺮﻑ‬ ‫ﻭﺣﻠﻖ‬ ‫ﮔﻮﺵ‬ ‫ﺑﻴﻤﺎﺭﻳﻬﺎﻱ‬ ‫ﺑﻬﺒﻮﺩ‬ ‫ژ‬ ‫ﻋﺮﻭﻗﻲ،ﺿﺪ‬ ‫ﻗﻠﺒﻲ‬ ‫ﺑﻴﻤﺎﺭﻳﻬﺎﻱ‬ ‫ﻭﺿﺪ‬ ‫ﻣﻴﻜﺮﻭﺑﻲ‬ ‫ﻭﺿﺪ‬ ‫ﻱ‬ ‫ﻣﻮﺛﺮ‬ ‫ﭘﻮﺳﺘﻲ‬ ‫ﻣﺸﻜﻼﺕ‬ ‫ﺑﺮﺧﻲ‬ ‫ﺩﻳﺎﺑﺖ،ﺩﺭﻣﺎﻥ‬ ‫،ﻛﻨﺘﺮﻝ‬ ‫ﺍﻟﺘﻬﺎﺑﻲ‬ ‫ﻭﺿﺪ‬ ‫ﺳﺮﻃﺎﻧﻲ‬ ‫ﻣﻲ‬ ‫ﺑﺎﺷﺪ‬. ‫ﻧﺘﻴﺠﻪ‬ ‫ﮔﻴﺮﻱ‬ : ‫ﻭﺩﺳﺘﺎﻭﺭﺩﻫﺎ‬ ‫ﻗﺪﻳﻢ‬ ‫ﺳﺎﻟﻪ‬ ‫ﺻﺪ‬ ‫ﭼﻨﺪ‬ ‫ﺗﺠﺮﺑﻴﺎﺕ‬ ‫ﺑﻪ‬ ‫ﺗﻮﺟﻪ‬ ‫ﺑﺎ‬ ‫ﺍﻧﺎﺭ‬ ‫ﮔﻴﺎﻩ‬ ‫ﺍﻣﺮﻭﺯ‬ ‫ﺩﺍﻧﺶ‬ ‫ﻱ‬ ‫ﻣﻲ‬ ‫ﺑـﻪ‬ ‫ﻣﻜﻤـﻞ‬ ‫ﺻﻮﺭﺕ‬ ‫ﺑﻪ‬ ‫ﻳﺎ‬ ‫ﺗﻨﻬﺎﻳﻲ‬ ‫ﺑﻪ‬ ‫ﺑﻴﻤﺎﺭﻳﻬﺎ‬ ‫ﺍﺯ‬ ‫ﺑﺴﻴﺎﺭﻱ‬ ‫ﺩﺭﻣﺎﻥ‬ ‫ﺩﺭ‬ ‫ﺗﻮﺍﻧﺪ‬ ‫ﺷﻮﺩ‬ ‫ﮔﺮﻓﺘﻪ‬ ‫ﻛﺎﺭ‬. ‫ﺗﻮﺻﻴﻪ‬ ‫ﺁﻧﻬﺎ‬ ‫ﺗﺠﺮﺑﻲ‬ ‫ﺑﺮﺭﺳﻲ‬ ‫ﻣﻲ‬ ‫ﺷﻮﺩ‬ ‫ﻛﻠﻴﺪﻭﺍژﻩ‬ ‫ﻫﺎ‬ : ‫ﻗﺒﺾ‬ ‫ﺍﻣﺮﻭﺯ،ﺧﺎﺻﻴﺖ‬ ‫ﺍﻳﺮﺍﻥ،ﻃﺐ‬ ‫ﺳﻨﺘﻲ‬ ‫ﺍﻧﺎﺭ،ﻃﺐ‬. ‫ﻣﻘﺪﻣﻪ‬ : ‫ﺷﻨﺎﺳـﻲ‬ ‫ﮔﻴـﺎﻩ‬ ‫ﻧـﺎﻡ‬ ‫ﺑـﺎ‬ ‫ﺍﻱ‬ ‫ﻣﻴـﻮﻩ‬ ‫‪‬ﺎﻥ،‬ ‫ﻣ‬ ‫ﺭ‬ ‫ﻋﺮﺑﻲ‬ ‫ﺑﻪ‬ ‫ﺍﻧﺎﺭ‬ Punica granatum ‫ﺗﻴﺮﻩ‬ ‫ﺍﺯ‬ punicaceae ‫ﻣﻲ‬ ‫ﺑﺎﺷﺪ‬. ‫ﺑﺎﺳـﺘﺎﻥ‬ ‫ﻻﺗـﻴﻦ‬ ‫ﺯﺑﺎﻥ‬ ‫ﺩﺭ‬ pumum ‫ﻭ‬ ‫ـﻴﺐ‬ ‫ﺳـ‬ ‫ـﺎﻱ‬ ‫ﻣﻌﻨـ‬ ‫ـﻪ‬ ‫ﺑـ‬ granatum ‫ـﺘﻪ‬ ‫ﻫﺴـ‬ ‫ـﺮ‬ ‫ﭘـ‬ ‫ـﻲ‬ ‫ﻣﻌﻨـ‬ ‫ـﻪ‬ ‫ﺑـ‬ ‫ﻣﻲ‬ ‫ﺑﺎﺷﺪ،‬ ‫ﺑﻨﺎﺑﺮﺍﻳﻦ‬ Punica granatum ‫ﻫﺴﺘﻪ‬ ‫ﭘﺮ‬ ‫ﺳﻴﺐ‬ ‫ﻳﻌﻨﻲ‬. ‫ﺍﺳـﺖ‬ ‫ﺍﻳﺮﺍﻥ‬ ‫ﺗﻤﺪﻥ‬ ‫ﺍﻧﺎﺭ‬ ‫ﺧﻮﺍﺳﺘﮕﺎﻩ‬. ‫ﺍﺯ‬ ‫ﺗـﺪﺭﻳﺞ‬ ‫ﺑـﻪ‬ ‫ﺁﻥ‬ ‫ﺍﺯ‬ ‫ﺑﻌـﺪ‬ ‫ﻳﺎﻓﺖ‬ ‫ﻫﻨﺪﮔﺴﺘﺮﺵ‬ ‫ﺷﻤﺎﻝ‬ ‫ﺗﺎ‬ ‫ﻣﺪﻳﺘﺮﺍﻧﻪ‬. ‫ﻗﺮﻥ‬ ‫ﺍﻭﺍﺧﺮ‬ ‫ﺩﺭ‬ ‫ﻣﻴﻮﻩ‬ ‫ﺍﻳﻦ‬ 19 ‫ﺷﺪ‬ ‫ﺁﻣﺮﻳﻜﺎ‬ ‫ﻭﺍﺭﺩ‬ ‫ﻭ‬ ‫ﻛﺸﺖ‬ ‫ﻣﺨﺘﻠﻒ‬ ‫ﻛﺸﻮﺭﻫﺎﻱ‬ ‫ﺩﺭ‬ ‫ﺍﻣﺮﻭﺯﻩ‬ ‫ﻣﻲ‬ ‫ﺷﻮﺩ‬. ‫ﺗ‬ ‫ﺑﺰﺭﮔﺘﺮﻳﻦ‬ ‫ﺍﻳﺮﺍﻥ‬ ‫ﻛﺸـﻮﺭ‬ ‫ﺩﻭﻣـﻴﻦ‬ ‫ﻭﻫﻨﺪﻭﺳـﺘﺎﻥ‬ ‫ﺩﻧﻴﺎ‬ ‫ﺍﻧﺎﺭ‬ ‫ﻮﻟﻴﺪﻛﻨﻨﺪﻩ‬ ‫ﺍﺳﺖ‬ .) 1 (‫ﺗـﺎ‬ ‫ﺣﺪﺍﻛﺜﺮ‬ ‫ﺁﻥ‬ ‫ﺍﺭﺗﻔﺎﻉ‬ ‫ﻛﻪ‬ ‫ﺍﺳﺖ‬ ‫ﻛﻮﭼﻜﻲ‬ ‫ﺩﺭﺧﺖ‬ ‫ﺍﻧﺎﺭ‬ 6 ‫ﻣﺘﺮ‬ ‫ﻣﻲ‬ ‫ﻣﻴﺮﻭﻳﺪ‬ ‫ﮔﺮﻣﺴﻴﺮﻱ‬ ‫ﻧﻴﻤﻪ‬ ‫ﻣﻨﺎﻃﻖ‬ ‫ﺩﺭ‬ ‫ﻭ‬ ‫ﺭﺳﺪ‬. ‫ﮔـﻞ‬ ‫ﻫـﺎﻱ‬ ‫ﺍﻧـﺎﺭ‬ ‫ﺑﻮ‬ ‫ﺑﻲ‬ ‫ﻭﻟﻲ‬ ‫ﺍﻧﺎﺭﻱ‬ ‫ﻗﺮﻣﺰ‬ ‫ﺭﻧﮓ‬ ‫ﺑﻪ‬ ‫ﺩﺭﺷﺖ،‬ ‫ﻣﻲ‬ ‫ﺑﺎﺷﺪ‬. ‫ﮔﻞ‬ ‫ﻫﺎﻱ‬ ‫ﺑﺮ‬ ‫ﺍﻧﺎﺭ‬ ‫ﺍﻧﺪ‬ ‫ﻧﻮﻉ‬ ‫ﺩﻭ‬ : ‫ﮔﻞ‬ ‫ﺍﻭﻝ‬ ‫ﺩﺳﺘﻪ‬ ‫ﻫـﺎﻱ‬ ‫ﺛﻤـﺮﻱ‬ ‫ﻳـﺎ‬ ‫ﺑـﺎﺭﺁﻭﺭ‬ (fruitful) ‫ﻛـﻪ‬ ‫ﺁﻥ‬ ‫ﺩﺭ‬ ‫ـﻪ‬ ‫ﻛـ‬ ‫ـﺘﻨﺪ‬ ‫ﻫﺴـ‬ ‫ـﺪ‬ ‫ﺑﻠﻨـ‬ ‫ـﺮﭼﻢ‬ ‫ﭘـ‬ ‫ﻭ‬ ‫ـﻪ‬ ‫ﺧﺎﻣـ‬ ‫ﺩﺍﺭﺍﻱ‬ ‫ﻭ‬ ‫ـﻮﺩﻩ‬ ‫ﺑـ‬ ‫ﺑﺰﺭﮔﺘـﺮ‬ ‫ﺑﺴﺎﻙ‬ ‫ﻫﺎ‬ ‫ﻛﻼﻟﻪ‬ ‫ﻭ‬ ‫ﻫﺎ‬ ‫ﻫﺴﺘﻨﺪ‬ ‫ﻗﺪ‬ ‫ﻫﻢ‬ ً ‫ﺗﻘﺮﻳﺒﺎ‬. ‫ﮔـﻞ‬ ‫ﺍﻳـﻦ‬ ‫ﻫـﺎ‬ ‫ﻭ‬ ‫ﻛﺸـﻴﺪﻩ‬ ‫ـﻞ‬ ‫ﮔـ‬ ‫ـﺮﺩﻥ‬ ‫ﮔـ‬ ‫ﺩﺭ‬ ‫ـﺎﻥ‬ ‫ﻗﻄﺮﺷـ‬ ‫ﺍﺯ‬ ‫ـﺘﺮ‬ ‫ﺑﻴﺸـ‬ ‫ـﺎﻝ‬ ‫ﺍﺗﺼـ‬ ‫ـﻞ‬ ‫ﻣﺤـ‬ ‫ﺩﺭ‬ ‫ـﺎﻥ‬ ‫ﻗﻄﺮﺷـ‬ ‫ﻣﻲ‬ ‫ﺑﺎﺷﺪ‬. ‫ﮔﻞ‬ ‫ﺩﻭﻡ‬ ‫ﺩﺳﺘﻪ‬ ‫ﻫﺎﻱ‬ ‫ﻭ‬ ‫ﻧﺎﺯﺍ‬ ‫ﻋﻠﻔﻲ‬ ‫ﻳﺎ‬ (barren) ‫ﻛـﻪ‬ ‫ﻫﺴﺘﻨﺪ‬ ‫ﺁﻧﻬـﺎ‬ ‫ﺩﺭ‬ ‫ﻭ‬ ‫ﺑـﻮﺩﻩ‬ ‫ﻛﻮﺗـﺎﻩ‬ ‫ﭘـﺮﭼﻢ‬ ‫ﻭ‬ ‫ﺧﺎﻣـﻪ‬ ‫ﺑﺎ‬ ‫ﺗﺮ‬ ‫ﻛﻮﭼﻚ‬ ‫ﺁﻧﻬﺎ‬ ‫ﺍﻧﺪﺍﺯﻩ‬ ‫ﻛﻼﻟﻪ‬ ‫ﻫﺎ‬ ‫ﺑﺴﺎﻙ‬ ‫ﺯﻳﺮ‬ ‫ﺩﺭ‬ ‫ﻭ‬ ‫ﺗﺮ‬ ‫ﻛﻮﺗﺎﻩ‬ ‫ﻫﺎ‬ ‫ﺩﺍﺭﻧﺪ‬ ‫ﻗﺮﺍﺭ‬. ‫ﮔـﻞ‬ ‫ﺍﻳﻦ‬ ‫ﻫـﺎ‬ ‫ﻛـﻪ‬ ً ‫ﺑﻌـﺪﺍ‬ ‫ﺍﺳـﺖ‬ ‫ﮔﺮﺩﻥ‬ ‫ﺩﺭ‬ ‫ﻗﻄﺮﺷﺎﻥ‬ ‫ﺍﺯ‬ ‫ﻛﻤﺘﺮ‬ ‫ﺍﺗﺼﺎﻝ‬ ‫ﻣﺤﻞ‬ ‫ﺩﺭ‬ ‫ﻗﻄﺮﺷﺎﻥ‬ ‫ﺗﺎﺭ‬ ‫ﻳ‬ ‫ﺦ‬ ‫ﺩﺭ‬ ‫ﻳ‬ ‫ﺎﻓﺖ‬ : ‫ﺍﺭﺩﻳﺒﻬﺸﺖ‬ 95 ‫ﭘﺬﻳﺮﺵ‬ ‫ﺗﺎﺭﻳﺦ‬ : ‫ﺑﻬﻤﻦ‬ 95
Article
With the transformation of health concepts and medical models, traditional medicine is receiving more and more attention from people all over the world. Traditional medicine has become an important part of health promotion and global health management improvement. This paper briefly describes the connotation and development trend of traditional medicine in the new era from the perspective of philosophical theory. Through a thorough analysis of the rational thinking and realistic basis for the integration and development of traditional medicine in the new era from the perspectives of time, space, content and technology, we come to the conclusion that, under the modern medical model supported by Big Health and Big Data, the deepening and improvement of the consolidation of multi-dimensional integration and multi-collaborative system of traditional medicine will play a more fundamental role in mankind’s health and hygiene. This paper also presents the paths of integrative development for the traditional medicine under the new circumstances, aiming to provide theoretical ideas for further promoting the systematic development of traditional medicine and helping the revival of traditional Chinese medical civilization.
Article
Full-text available
Depression represents a major public health problem. It is estimated that 13-20% of the population has some depressive symptoms at any given time and about 5% of the population is assumed to suffer from major depression. Known pathological processes include ischemia, neoplasia, necrosis, apoptosis, infection, and inflammation. Of those, inflammation is the most compatible with the waxing and waning course of depression, and could explain the biology of this disorder that has a fluctuating course with severe episodes that can be followed by partial or complete remission. Over the years a body of evidence has been accumulated suggesting that major depression is associated with dysfunction of inflammatory mediators. Major depression commonly co-occurs with ischemic heart disease and decreased bone mineral density. Depressive symptoms are known to have a negative impact on cardiovascular prognosis, increasing the mortality rate of coronary artery disease. Several lines of evidence indicate that brain cytokines, principally interleukin-1beta (IL-1beta) and IL-1 receptor antagonist may have a role in the biology of major depression, and that they might additionally be involved in the pathophysiology and somatic consequences of depression as well as in the effects of antidepressant treatment. A particularly unique and novel aspect of the studies and views discussed here is their potential to lead to interventions which may reduce the morbidity and mortality risks for osteoporosis, cardiovascular disease, and behavioral symptoms in patients with major depression. We also discuss the emerging concept of peripheral and central cytokine compartments: their integration and differential regulation is a key element for the optimal functioning of the immune and nervous systems.
Article
The aim of this review was to assess controlled clinical trials of Hypericum as a treatment for depression. A systematic, combined computer and hand search revealed fourteen studies conducted against placebo and four against standard medication. Eight of the former and three of the latter met the predetermined methodological inclusion criteria and were admitted for analysis. The cumulative data shows that Hypericum is superior to placebo in alleviating symptoms of depression as quantified by the Hamilton Scale. It also seems equally effective as standard medication; the frequency of adverse drug reactions shows a clear advantage of the herbal over synthetic antidepressants. It is concluded that Hypericum is a safe and effective symptomatic treatment for various forms of depressions.
Article
In a randomized, double-blind, placebo-controlled, multicenter study, the clinical efficacy and safety of two different extracts of St. John's wort were investigated in 147 male and female out-patients suffering from mild or moderate depression according to DSM-IV criteria. Fifty-six (38.1%) of them had an initial total score ≥ 22 points on the Hamilton Rating Scale for Depression (HAMD, 17-item version). Following a placebo run-in period of three to seven days, the patients were randomized to one of three treatment groups: During the 42-day treatment period, they received 3×1 tablet of either placebo, Hypericum extract WS 5573 (300mg, with a content of 0.5% hyperforin), or Hypericum extract WS 5572 (300 mg, with a content of 5% hyperforin). The manufacturing process for both Hypericum preparations was identical, they only differed with regard to their content of hyperforin. Efficacy regarding depressive symptoms was assessed on days 0, 7,14,28, and 42. The last observation of patients withdrawn from the trial prematurely was carried forward. At the end of the treatment period (day 42), the patients receiving WS 5572 (5% hyperforin) exhibited the largest HAMD reduction versus day 0 (10.3 ± 4.6 points; mean ± SD), followed by the WS 5573 group (0.5% hyperforin; HAMD reduction 8.5 ± 6.1 points) and the placebo group (7.9 ± 5.2 points). The monotonie trend was significant (Jonckheere-Terpstra test; p = 0.017). In patients with an initial HAMD total score ≥ 22, the HAMD reduction was even by 16.5% larger than in the total study group receiving WS 5572. More severely depressed patients treated with WS 5573, however, showed a 22.4% lower reduction of the HAMD total score than the entire WS 5573 treatment group. In patients with HAMD ≥ 22, WS 5572 showed a 53.8% larger HAMD reduction than placebo, whereas WS 5573 was not relevantly different from the placebo level. The mean HAMD reductions, treatment end versus baseline, for the more severely depressed patients were 12.0 (3.7) points, 6.6 (7.7) points and 7.8 (5.4) points [mean (SD)] for WS 5S72, WS 5573 and placebo, respectively. The results of a responder analysis support these findings. The data point to a dose-response relationship between the antidepressant efficacy of Hypericum extract and its hyperforin content. The extract with a higher content of hyperforin was particularly effective in patients who were more severely depressed.
Article
The antioxidant activity of pomegranate juices was evaluated by four different methods (ABTS, DPPH, DMPD, and FRAP) and compared to those of red wine and a green tea infusion. Commercial pomegranate juices showed an antioxidant activity (18−20 TEAC) three times higher than those of red wine and green tea (6−8 TEAC). The activity was higher in commercial juices extracted from whole pomegranates than in experimental juices obtained from the arils only (12−14 TEAC). HPLC-DAD and HPLC-MS analyses of the juices revealed that commercial juices contained the pomegranate tannin punicalagin (1500−1900 mg/L) while only traces of this compound were detected in the experimental juice obtained from arils in the laboratory. This shows that pomegranate industrial processing extracts some of the hydrolyzable tannins present in the fruit rind. This could account for the higher antioxidant activity of commercial juices compared to the experimental ones. In addition, anthocyanins, ellagic acid derivatives, and hydrolyzable tannins were detected and quantified in the pomegranate juices. Keywords: Pomegranate; Punica granatum; Punicaceae; juice; phenolics; anthocyanins; ellagic acid; punicalagin; tannins; antioxidant activity; ABTS; DPPH; DMPD; FRAP
Article
A MAJOR problem in the search for new antidepressant drugs is the lack of animal models which both resemble depressive illness and are selectively sensitive to clinically effective antidepressant treatments. We have been working on a new behavioural model in the rat which attempts to meet these two requirements. The method is based on the observation that a rat, when forced to swim in a situation from which there is no escape, will, after an initial period of vigorous activity, eventually cease to move altogether making only those movements necessary to keep its head above water. We think that this characteristic and readily identifiable behavioural immobility indicates a state of despair in which the rat has learned that escape is impossible and resigns itself to the experimental conditions. This hypothesis receives support from results presented below which indicate that immobility is reduced by different treatments known to be therapeutic in depression including three drugs, iprindole, mianserin and viloxazine which although clinically active1-3 show little or no `antidepressant' activity in the usual animal tests4-6.
Article
The forced swimming test is reviewed. This test appears to be suitable for detecting antidepressant activity in rats but not in mice. Difference in experimental procedure may account for the different sensitivity to drugs of the two animal species.
Article
The antioxidant and eicosanoid enzyme inhibition properties of pomegranate (Punica granatum) fermented juice and seed oil flavonoids were studied. The pomegranate fermented juice (pfj) and cold pressed seed oil (pcpso) showed strong antioxidant activity close to that of butylated hydroxyanisole (BHA) and green tea (Thea sinensis), and significantly greater than that of red wine (Vitis vitifera). Flavonoids extracted from pcpso showed 31-44% inhibition of sheep cyclooxygenase and 69-81% inhibition of soybean lipoxygenase. Flavonoids extracted from pfj showed 21-30% inhibition of soybean lipoxygenase though no significant inhibition of sheep cyclooxygenase. The pcpso was analyzed for its polyphenol content and fatty acid composition. Total polyphenols in pcpso showed a concentration by weight of approximately 0.015%. Pcpso fatty acid composition showed punicic acid (65.3%) along with palmitic acid (4.8%), stearic acid (2.3%), oleic acid (6.3%), linoleic acid (6.6%) and three unidentified peaks from which two (14.2%) are probably isomers of punicic acid (El-Shaarawy, M.I., Nahpetian, A., 1983). Studies on pomegranate seed oil. Fette Seifen Anstrichmittel 83(3), 123-126).
Article
Pomegranate is known to contain estrogens (estradiol, estrone, and estriol) and show estrogenic activities in mice. In this study, we investigated whether pomegranate extract is effective on experimental menopausal syndrome in ovariectomized mice. Prolongation of the immobility time in forced swimming test, an index of depression, was measured 14 days after ovariectomy. The bone mineral density (BMD) of the tibia was measured by X-ray absorptiometry and the structure and metabolism of bone were also analyzed by bone histomorphometry. Administration of pomegranate extract (juice and seed extract) for 2 weeks to ovariectomized mice prevented the loss of uterus weight and shortened the immobility time compared with 5% glucose-dosed mice (control). In addition, ovariectomy-induced decrease of BMD was normalized by administration of the pomegranate extract. The bone volume and the trabecular number were significantly increased and the trabecular separation was decreased in the pomegranate-dosed group compared with the control group. Some histological bone formation/resorption parameters were significantly increased by ovariectomy but were normalized by administration of the pomegranate extract. These changes suggest that the pomegranate extract inhibits ovariectomy-stimulated bone turnover. It is thus conceivable that pomegranate is clinically effective on a depressive state and bone loss in menopausal syndrome in women.
Article
A search for novel pharmacotherapy from medicinal plants for psychiatric illnesses has progressed significantly in the past decade. This is reflected in the large number of herbal preparations for which psychotherapeutic potential has been evaluated in a variety of animal models. The objective of this review is to provide an overview of herbal extracts and constituents that have significant therapeutic effects in animal models of psychiatric illnesses. Eighty five individual herbs reviewed were classified as anxiolytic, antidepressant, neuroleptic, antidementia, or anti-substance abuse herbs. The full scientific name of each herb, herbal part used, active constituent, extract, dose range and route, animal model, possible mechanisms of action, and pertinent references are presented via synoptic tables. The herbal mixtures were also mentioned. A considerable number of herbal constituents whose behavioral effects and pharmacological actions have been well characterized may be good candidates for further investigations that may ultimately result in clinical use. The investigation of a large portion of the herbal extracts and herbal mixtures is in its infancy. Herbal remedies that have demonstrable psychotherapeutic activities have provided a potential to psychiatric pharmaceuticals and deserve increased attention in future studies.